Showing 26–50 of 127 international scientific journals (Pharmacy)
| Rank | Journal Name & ISSN | Country | WoS Quartile | CAS Division | Impact Factor | Scopus SJR | H-Index | Docs/yr | Self-Citation | Publisher | Profile |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 26 | AAPS Pharmscitech ISSN: 1530-9932 | 🇺🇸United States | Q1 | CAS Tier 3 | 5.1 | 0.721Q1 | 79 | 297 | 2.9% | Springer International Publishing | Profile |
| 27 | European Journal of Pharmaceutical Sciences ISSN: 0928-0987 / 1879-0720 | 🇳🇱Netherlands | Q1 | CAS Tier 2 | 5.1 | 0.951Q1 | 119 | 375 | 2.3% | Elsevier | Profile |
| 28 | Expert Opinion on Therapeutic Targets ISSN: 1472-8222 / 1744-7631Top Tier | 🇬🇧United Kingdom | Q1 | CAS Tier 3 | 5.1 | 1.383Q1 | 78 | 70 | 2.2% | Taylor and Francis Ltd. | Profile |
| 29 | European Journal of Pharmaceutics and Biopharmaceutics ISSN: 0939-6411 / 1873-3441 | 🇳🇱Netherlands | Q1 | CAS Tier 3 | 5 | 0.848Q1 | 138 | 235 | 2.3% | Elsevier | Profile |
| 30 | Biomolecules & Therapeutics ISSN: 1976-9148 / 2005-4483 | 🌐South Korea | Q1 | CAS Tier 3 | 4.9 | 0.969Q2 | 26 | 93 | 6.7% | Korean Society of Applied Pharmacology | Profile |
| 31 | Clinical Pharmacology & Therapeutics ISSN: 0009-9236 / 1532-6535Top Tier | 🇺🇸United States | Q1 | CAS Tier 2 | 4.9 | 1.856Q1 | 173 | 260 | 7.9% | Wiley-Blackwell | Profile |
| 32 | Molecular Pharmaceutics ISSN: 1543-8384 / 1543-8392 | 🇺🇸United States | Q2 | CAS Tier 2 | 4.9 | 0.957Q1 | 110 | 384 | 6.7% | American Chemical Society | Profile |
| 33 | Advances in Therapy ISSN: 0741-238X / 1865-8652 | 🇬🇧United Kingdom | Q2 | CAS Tier 2 | 4.7 | 1.418Q1 | 53 | 356 | 2.9% | Springer Healthcare | Profile |
| 34 | Drug Metabolism Reviews ISSN: 0360-2532 / 1097-9883Top Tier | 🇺🇸United States | Q1 | CAS Tier 3 | 4.7 | 0.93Q1 | 89 | 24 | 2.9% | Informa Healthcare | Profile |
| 35 | Expert Opinion on Therapeutic Patents ISSN: 1354-3776 / 1744-7674Top Tier | 🇬🇧United Kingdom | Q2 | CAS Tier 3 | 4.7 | 1.098Q1 | 61 | 66 | 1.9% | Taylor and Francis Ltd. | Profile |
| 36 | Journal of Drug Targeting ISSN: 1061-186X / 1029-2330 | 🇬🇧United Kingdom | Q1 | CAS Tier 3 | 4.7 | 0.829Q1 | 80 | 80 | 0% | Informa Healthcare | Profile |
| 37 | Pharmacoeconomics ISSN: 1170-7690 / 1179-2027 | 🌐New Zealand | Q1 | CAS Tier 2 | 4.7 | 1.807Q1 | 91 | 108 | 9.1% | Springer International Publishing | Profile |
| 38 | Expert Review of Anti-Infective Therapy ISSN: 1478-7210 / 1744-8336Top Tier | 🇬🇧United Kingdom | Q1 | CAS Tier 3 | 4.6 | 1.024Q1 | 65 | 116 | 2.4% | Taylor and Francis Ltd. | Profile |
| 39 | Pharmacological Reports ISSN: 1734-1140 / 2299-5684 | 🌐Poland | Q2 | CAS Tier 3 | 4.5 | 1.016Q1 | 71 | 135 | 0% | Springer International Publishing | Profile |
| 40 | Expert Opinion on Investigational Drugs ISSN: 1354-3784 / 1744-7658Top Tier | 🇬🇧United Kingdom | Q2 | CAS Tier 3 | 4.3 | 1.199Q1 | 94 | 97 | 0% | Taylor and Francis Ltd. | Profile |
| 41 | Journal of Pharmacology and Experimental Therapeutics ISSN: 0022-3565 / 1521-0103 | 🇺🇸United States | Q2 | CAS Tier 3 | 4.3 | 0.921Q2 | 209 | 145 | 6.5% | American Society for Pharmacology and Experimental Therapeutics | Profile |
| 42 | Clinical Pharmacokinetics ISSN: 0312-5963 / 1179-1926 | 🌐New Zealand | Q2 | CAS Tier 2 | 4 | 1.211Q1 | 150 | 113 | 4.3% | Springer International Publishing | Profile |
| 43 | Naunyn-Schmiedebergs Archives of Pharmacology ISSN: 0028-1298 / 1432-1912 | 🇩🇪Germany | Q2 | CAS Tier 3 | 4 | 0.877Q2 | 83 | 134 | 6.5% | Springer Berlin Heidelberg | Profile |
| 44 | Pharmacotherapy ISSN: 0277-0008 / 1875-9114 | 🇺🇸United States | Q2 | CAS Tier 3 | 4 | 1.189Q1 | 99 | 102 | 6.9% | Wiley-Blackwell | Profile |
| 45 | Expert Opinion on Emerging Drugs ISSN: 1472-8214 / 1744-7623Top Tier | 🇬🇧United Kingdom | Q2 | CAS Tier 3 | 3.8 | 0.908Q2 | 43 | 31 | 0% | Taylor and Francis Ltd. | Profile |
| 46 | Clinical Therapeutics ISSN: 0149-2918 / 1879-114X | 🇺🇸United States | Q2 | CAS Tier 3 | 3.7 | 1.041Q1 | 123 | 169 | 0% | Elsevier Inc. | Profile |
| 47 | Journal of Natural Products ISSN: 0163-3864 / 1520-6025Top Tier | 🇺🇸United States | Q2 | CAS Tier 2 | 3.7 | 0.585Q1 | 124 | 351 | 6.1% | American Chemical Society | Profile |
| 48 | Journal of Pharmacy and Pharmacology ISSN: 0022-3573 / 2042-7158 | 🇬🇧United Kingdom | Q2 | CAS Tier 3 | 3.7 | 0.765Q2 | 107 | 193 | 0% | Wiley-Blackwell | Profile |
| 49 | Vascular Pharmacology ISSN: 1537-1891 / 1879-3649 | 🇺🇸United States | Q2 | CAS Tier 3 | 3.7 | 0.99Q2 | 86 | 66 | 2.9% | Elsevier Inc. | Profile |
| 50 | Drug Metabolism and Disposition ISSN: 0090-9556 / 1521-009X | 🇺🇸United States | Q2 | CAS Tier 3 | 3.6 | 1.054Q1 | 161 | 99 | 15.9% | American Society for Pharmacology and Experimental Therapeutics | Profile |